WHO Recommends Regen-COV for COVID-19 Patients at High Risk of Hospital Admission
A WHO panel of international experts and patients has recommended Regeneron's Regen-COV (casirivimab and imdevimab) for two groups of COVID-19 patients.
Tag: COVID-19
All
Latest
All
Latest
Pfizer Vaccine Safe for Children Age 5-11
Administering a 10 ug dose of the Pfizer/BioNTech COVID-19 vaccine in children age 5-11 was safe and effective, according to a Phase 2/3 trial.
All
Latest
Public Reluctancy to Perform Bystander CPR Due to COVID-19
Sixty-one percent of surveyed respondents had negative attitudes toward performing potentially-lifesaving bystander CPR, in the face of exposure to or transmission of an emerging infectious disease outbreak, such as COVID-19.
Early COVID-19 Symptoms Differ Between Men and Women, Young and Old
Men and women present COVID-19 symptoms differently, with men more likely to report dyspnea, fatigue, chills, and shivers, while women were more likely to report loss of smell, chest pain, and chronic cough.
Read More
Vitalograph Podcast will “Ask the Respiratory Therapist”
Vitalograph Inc’s Exhale podcast will air a series of special editions titled “Ask the Respiratory Therapist” that will focus on frontline healthcare during the COVID-19 pandemic.
Read More
Preprint: CPAP Reduces Need for Invasive Ventilation in Hospitalized COVID-19 Patients
Treating hospitalized COVID-19 patients who have acute respiratory failure with continuous positive airway pressure (CPAP) reduces the need for invasive mechanical ventilation.
Read More
Medicaid Vaccination Rates Founder as States Struggle to Immunize Their Poorest Residents
Medicaid enrollees are getting vaccinated against covid-19 at far lower rates than the general population as states search for the best strategies to improve access to the shots.
Read More
States Pull Back on Covid Data Even Amid Delta Surge
Two state government websites in Georgia recently stopped posting updates on covid-19 cases in prisons and long-term care facilities, just as the dangerous delta variant was taking hold.
Read More
AstraZeneca Monoclonal Antibody Effective as Preventative Therapy
AZD7442, a monoclonal antibody cocktail against the COVID-19 virus, reduced the risk of symptoms in a study of immunocompromised and chronically ill adults later exposed to the virus by 77%, according to AstraZeneca.
Read More
Study: Will There be Lung Damage After Full Recovery From COVID-19?
New research shows that many COVID survivors will be spared long-term respiratory damage.
Read More
COVID-19 Risk in Cystic Fibrosis Patients
Cystic fibrosis patients do not appear to have a greater risk for SARS-CoV-2 infection based on published evidence to date, according to a recent literature review.
Read More
Early COVID-19 vaccine campaign in US Prevented 140,000 Deaths
The early COVID-19 vaccination campaign in the US prevented nearly 140,000 deaths and 3 million cases of COVID-19 by the second week of May 2021.
Read More
Antibody Protects Against Variants
Researchers have identified an antibody that is highly protective at low doses against a wide range of COVID-19 variants.
Read More
FDA Approves Pfizer/BioNTech COVID-19 Vaccine for Ages 16+
The US FDA has approved the Pfizer-BioNTech COVID-19 Vaccine (now marketed as “Comirnaty”) for individuals 16 years of age and older — the first COVID-19 vaccine to be approved by the agency.
Read More
Moderna Vaccine Effective for Six Months Against Variants
The majority of individuals vaccinated with the Moderna COVID-19 vaccine maintained both binding and functional antibodies against SARS-CoV-2 variants for six months after the second dose.
Read More